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After infection  with  bacillus  Calmette-Gu6rin  (BCG) 1 the  host  may acquire  im- 
munity to specific secondary challenge,  protection  against  unrelated  virulent  orga- 
nisms such as Listeria monocytogenes,  and increased resistance to transplantable tumors 
(1-3).  Macrophages from such animals spread rapidly in culture, secrete high levels 
of H202 (4) and plasminogen activator (PA)  (5) when stimulated further, and display 
an  enhanced  capacity  to  kill  microorganisms  and  tumor  cells  (6,  7).  Although 
macrophages  obtained  from  mice  after  intraperitoneal  injection  of thioglycollate 
broth also show increased spreading and secretion of PA compared with resident cells 
from untreated animals, the cells elicited by this inflammatory stimulus do not exhibit 
microbicidal or tumoricidal activity and do not release substantial levels of H202 (6). 
Very  little  is  known  about  the  role  of surface  molecules  of the  BCG-activated 
macrophage in recognition of organisms and other cells and in control of the secretory 
activity of the  macrophage.  Recently,  several  specific receptors  and  antigens  have 
been defined on macrophages including a  lectin-like receptor that mediates endocy- 
tosis  of mannose-  or  fucose-terminal  glycoproteins  (M,FR)  (8),  an  Fc  receptor  (9) 
which binds and internalizes certain classes of immunoglobulin (FcR), and F4/80, an 
antigenic marker for the mature mouse macrophage.  2 In addition, macrophages can 
be induced  to express Ia antigens  by various infectious  and  other stimuli  (10,  11). 
Specific ligands and monoclonal antibodies are therefore available to study the effects 
of cell activation on expression of these plasma membrane determinants. 
We  report  here  that  intraperitoneal  infection with  live BCG organisms yields  a 
population of macrophages, activated by conventional criteria, which differs strikingly 
in its surface properties when compared with thioglycollate-elicited and resident ceils. 
Expression  of the  endocytic  receptors  and  of F4/80  is markedly reduced  in  BCG- 
* Supported in part by grants from the Medical Research Council and the University of Cape Town 
(R.A.B.E.). 
1 Abbreviations used in this paper: BCG, bacillus Calmette-Gu(~rin; BCG-PM, BCG-activated peritoneal 
macrophages; BSA, bovine serum albumin; DMEM, Dulbecco's  modification of Eagle's minimal essential 
medium; FBS, fetal bovine serum; FcR, Fc receptor; M,FR mannose, fucosyl receptor; OF, superoxide 
anion; PA, plasminogen activator; PBS, phosphate-buffered saline; PMA, phorbol myristate acetate; 
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activated macrophages at  the same time as Ia antigen  is enhanced.  Cell activation, 
therefore, results in an apparent reversal in surface phenotype of the cultivated mouse 
peritoneal macrophage. 
Materials  and  Methods 
Animals.  Mice were  bred  at  the  Sir William Dunn  School  of Pathology,  University of 
Oxford, Oxford, and both sexes used at weights of 22-30 g. Swiss Pathology Oxford (PO) mice, 
CBA TsT6 (H-2k), or BALB/c (H-2  a) mice were used for experiments as noted. 
Media and Reagents.  Dulbecco's modification of Eagle's minimal essential medium (DMEM) 
was obtained from Gibco-Biocult Ltd. (Paisley, Scotland). Fetal bovine serum (FBS) from the 
same source was routinely heat inactivated (56°C for 30 min) before use. 100 #g/ml Kanamycin, 
50 #g/ml streptomycin, and 50 #g/ml penicillin were added to all media. Phosphate-buffered 
saline (PBS) was obtained from Oxoid Ltd. (Basingstoke, England) and routinely used without 
calcium or magnesium except for assays of mannose-specific endocytosis when  calcium  (1.2 
mmol) and magnesium (1.2 mmol) were added. 
Ligands.  A glycoconjugate of mannose-bovine serum albumin (mannose-BSA) with 33-37 
mol of sugar/1  mol protein was prepared by the method of Stahl et al. (8), trace-labeled with 
1251 (12),  and  used  at  asp  act of 3.5  ×  106 cpm/#g, fl-Glucuronidase, a  glycoprotein with 
terminal  mannose,  was  purified from  rat  preputial glands, labeled, and  used  at  a  specific 
activity of 1 ×  106 cpm/#g (13). Mannan from bakers' yeast was bought from Sigma Chemical 
Co., St. Louis, Mo. (catalogue M-7504). 
Antibodies.  OX-4, a monoclonal mouse anti Ia  k~ antibody was a  generous gift of Dr. A. F. 
Williams, University of Oxford  (14).  F4/80,  a  rat  monoclonal  antibody specific for mouse 
macrophages, was used as a concentrated supernate. The rat anti-mouse Fc receptor antibody, 
2.4G2,  was  kindly provided as  a  purified protein  by  Dr. J.  C.  Unkeless,  The  Rockefeller 
University, New York (15). An affinity-purified F(ab')2 fragment of rabbit anti-rat Fab (RAR) 
was prepared by S. Hirsch in our laboratory at the Sir William Dunn School of Pathology by 
the method of Jensenius and Williams (16),  and trace-labeled for indirect binding assays as 
described elsewhere.  2 This reagent cross-reacts with mouse Ig. 
lnhibitors.  Superoxide dismutase (catalogue S.8254), catalase (catalogue C-100), and indo- 
methacin were obtained from the Sigma Chemical Co. All other reagents used were highest 
grade available from standard commercial suppliers. 
Peritoneal Cells.  Resident  peritoneal macrophages  (RPM)  were obtained from  untreated 
animals and thioglycollate-elicited  macrophages (TPM) 4-5 d after intraperitoneal injection of 
thioglycollate broth. BCG-activated peritoneal macrophages (BCG-PM) were obtained 10-21 
d after intraperitoneal infection with  1 ×  107 live organisms, Pasteur strain 1011, obtained as 
a generous gift from Dr. R. North, Trudeau Institute, Saranac Lake, N. Y. The organisms were 
stored  at  -70°C,  thawed,  and  sonicated  briefly before  use.  Peritoneal cells were  washed, 
resuspended in medium (DMEM +  5% FBS), and plated in 24- or 96-well tissue culture trays 
(Linbro Chemical Co., Flow, Irvine, England)  at 5  ×  10  s or 2  ×  105 macrophages per well, 
respectively. The number of macrophages in peritoneal washouts was determined in a  hemo- 
cytometer after staining with Turk's solution. BCG-infected animals yielded ~5  ×  106 cells 
with 45-55% macrophages,  10-15% polymorphonuclear leukocytes (PMN), and 30-40% lym- 
phocytes. 
Adherent cell monolayers were prepared after a 4-h incubation at 37°C in the presence of 
5% CO2 by washing twice with PBS. Differential counts of glutaraldehyde-fixed adherent cells 
were  made  by phase-contrast  microscopy using standard  morphologic criteria and  showed 
>90% macrophages in RPM and TPM preparations. BCG-activated adherent cells consisted 
of ~85%  macrophages,  7% lymphocytes, 6%  PMN,  and  2%  dendritic cells. No attempt was 
made to recover nonadherent macrophages in peritoneal populations. Adherent cell monolayers 
will be referred to as macrophages and were either used in various assays at this stage or after 
further cultivation in DMEM +  10% FBS for 60 h. 
Cell viability was estimated by trypan blue dye exclusion, phase-contrast microscopy, and 
by lysozyme production (17).  Adherent cells from all preparations showed >95% viability by 
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emulphogene  (0.25%) and  binding of  a  Bio-Rad  dye  reagent  for  cell  protein  (Bio-Rad 
Laboratories, Munich, Federal Republic of Germany). This method gave results similar to 
those obtained with the Lowry method (18), using an egg lysozyme standard. In all cases, the 
cell protein recovered was directly proportional to the number of macrophages plated, 
Assays: Mannose-specific Endocytosis.  The  binding and  uptake  of ligands were  assayed  at 
saturating concentrations of ligand using trace-labeled mannose-BSA and/3-glucuronidase in 
the paresence or absence of yeast mannan, a potent competitor of mannose-specific endocytosis 
(19).  Adherent macrophages  from  different sources  were  assayed  except  for  some binding 
assays that were also performed with total peritoneal cell populations freshly harvested from 
the animal. 
Binding was assayed at 4°C. The reaction mixture contained Ca  ++ and Mg  ++, which are 
required for  binding, and FBS, which contains little inhibitor of mannose-specific binding, 
unlike horse serum. 
Routinely, 4-h-adherent macrophages were washed three times in PBS and incubated in a 
reaction vol of 300 ~1 with DMEM +  10% FBS, with 10 mm Hepes buffer, pH 7.0, and 0.1-0.5 
~g/well, x25I-mannose BSA,  with or without  1.25-2.5  mg mannan. Cells were  incubated in 
duplicate for 60 min at 4°C and washed three times in ice-cold PBS with 10 mm sodium azide. 
200/~l/well of 0.25% Emulphogene was added to dissolve the cells and the radioactivity bound 
measured in a Packard gamma spectrometer (Packard Instrument Co., Inc., Downers Grove, 
Ill.). Cell protein was assayed by dye binding. Results were expressed as nanograms of mannose- 
BSA specifically bound per  5  ×  10  -5 maerophages plated.  Nonspecific binding was always 
<5% of specific binding. 
Assays with 125I-fl-glucuronidase were done similarly except that a higher concentration of 
ligand (300/~g/ml) was required to saturate specific receptors.  Cells in suspension were assayed 
in  microfuge tubes  over  a  layer of oil,  and  the  amount of ligand bound estimated  after 
centrifugation, as described elsewhere  (8). 
Uptake.  Macrophages were incubated in 300/~1 of DMEM +  10%  FBS with  14/~g  12nI- 
mannose BSA, with or without 1.25-2.5  mg mannan. After 10-30 min at 37°C, the cells were 
washed five times, lysed,  and analyzed as above. Control studies showed that specific uptake 
reached saturation after 10 min at the concentration  of ligand used and that nonspecific uptake 
was <5%.  Degradation of x25I-mannose-BSA, as  measured by appearance of trichloroacetic 
acid-soluble labeled material in the medium, was detectable after longer periods of incubation, 
but was less rapid with 125I-fl glucuronidase. 
Saturation Indirect-binding Assays for Macrophage Antigens.  Binding of monoclonal antibodies to 
live macrophages was detected by a second incubation with ~25I-labeled RAR. Both first- and 
second-stage antibodies were used at saturating concentrations so that  the number of RAR 
molecules bound was proportional to the number of first-stage antibody molecules and thus 
represented a measure of antigen expression.  2 Adherent cells were incubated with monoclonal 
antibody at 4°C in the presence of sodium azide for 60 min, washed, and incubated further 
with 50 #1 unlabeled RAR, (25/~g/ml), plus trace amounts of a2SI-RAR (2 ×  105 cpm per well). 
Control preparations without first antibody showed <5% of binding. The number of molecules 
of RAR  bound specifically was  calculated using a  value of 6  X  l0  g F(ab')2 molecules/ng 
protein. Results were expressed  as number of RAR molecules bound per macrophage plated. 
Single-Cell  Analysis:  Uptake of t~SI-Mannose BSA.  Cover slip  preparations of 4-h-adherent 
macrophages were incubated with  16 p.g/ml x25I-mannose BSA with or without  1.25 mg/ml 
mannan, for 10 min at 37°C. The cells were then washed well, fixed in methanol, and processed 
for radioautography by standard procedures. Preparations were stained with Giemsa, and at 
least 300 cells examined in duplicate preparations. Cells with > 10 grains were scored as labeled, 
and mannan-treated controls showed no labeling. 
Antigen Analysis.  Cover slip preparations were incubated with saturating concentrations of 
monoclonal antibody and with trace amounts of 125I-RAR (6 ×  105 cpm/coverslip). Radioau- 
tographs were prepared and scored as cells with >50, >20, or without grains. 
Assays of Macrophage Secretory Products.  Fibrinolysis by intact macrophages was assayed on 
125I-fibrin plates as described (20). Different concentrations of maerophages (6 X  104-5 ×  105) 
3 Stahl,  P.,  and S.  Gordon. Expression of a  mannosyl-fucosyl receptor for endocytosis on cultured 
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were assayed after a 4-h adherence, using acid-treated dog serum as source of plasminogen. No 
plasminogen-independent fibrinolysis was detected. 
Hydrogen  peroxide  release  was  assayed  by  the  methods  of Nathan  and  Root  (4)  using 
phorbol  myristate  acetate  (0.02  /tg/ml)  as  stimulus.  Superoxide  anion  was  assayed  by  the 
method of  Johnston et al. (21). 
Lysozyme was assayed by the lysoplate method with chick egg lysozyme as standard (22). 
Uptake of BCG Organisms by RPM.  RPM were plated for 4 h in DMEM +  5% FBS, washed, 
and then pulsed with  1 X  10  7 live organisms/5 X  105 macrophages for 100 min, washed twice 
in PBS, and then incubated at 37°C for 18 h in DMEM +  5% FBS (23). Binding of antibodies 
F4/80, 2.4G2, and OX-4, and uptake of 125I-mannose-BSA were measured, and cell-associated 
organisms counted in Zieht Neelson-stained preparations. 
Results 
General Considerations.  Intraperitoneal  infection by live BCG organisms provides a 
useful  method  to  obtain  activated  macrophages  in  the  mouse.  These  cells  can  be 
readily purified by 2-4 h  adherence to tissue culture vessels in the presence of serum, 
and  display rapid  spreading  and  active membrane  ruffling on glass cover slips.  On 
examination  by  phase-contrast  microscopy  (Fig.  1 A),  it  was  noted  that  BCG-PM 
differed morphologically from TPM  and RPM. Although some cells were well spread 
and  actively  endocytic,  other  cells  were  smaller  and  had  relatively  few  endocytic 
organelles  in  their  cytoplasm,  especially  when  compared  with  TPM.  Morphologic 
features  of intense  plasma  membrane  activity  combined  with  minimal  endocytosis 
persisted for several days after further cultivation (Fig.  1 B). It was therefore of interest 
FIG.  I.  Phase-contrast micrographs of BCG-PM (A) 4 h and (B) 60 h after cultivation in DMEM 
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to compare the ability of different peritoneal macrophages to endocytose ligands via 
specific surface receptors. 
Mannose-specific  Endocytosis.  Rat  alveolar  macrophages  bind  and  internalize  a 
variety of glycoproteins and glycoconjugates via a specific plasma membrane receptor 
(19). A similar receptor has recently been detected on TPM,  a but does not occur on 
other cells like PMN, lymphocytes, or fibroblasts. Binding and uptake of radiolabeled 
mannose-BSA or fl-glucuronidase by macrophages can be specifically prevented by 
mannose-rich yeast mannan.  Fig.  2 shows mannose-specific binding and uptake of 
125I-mannose-BSA  by BCG-PM  and TPM.  Whereas TPM  showed a  high level of 
receptor activity, approaching saturation  under conditions comparable  with those 
reported earlier for rat alveolar macrophages, both binding and uptake of ligand by 
BCG-PM were markedly depressed:  6 and 25% of TPM  activity, respectively. The 
low level of activity by BCG-PM was still saturable  and completely inhibited by 
mannan,  and  was  independent  of the  concentration of ligand or the  duration of 
incubation. Mannose-specific degradation by BCG-PM was reduced to 20% of that 
by TPM.  Similar results were obtained with a  different ligand, 125I-fl-glucuronidase 
and  diminished binding of 12~I-mannose-BSA  was  also  observed  with  total  BCG- 
peritoneal  cells  assayed  in  suspension,  without  fractionation by  adherence.  These 
results were highly reproducible and were confirmed in five independent experiments. 
Radioautographic studies (Fig.  3) showed that all thioglycollate-elicited cells with 
macrophage morphology were labeled by a25I-mannose-BSA  (>10  grains/cell)  and 
that BCG-PM were less heavily labeled. PMN and lymphocytes in both cell popula- 
tions were unlabeled, and uptake by macrophages was  inhibited by mannan.  We 
concluded that mannose-specific uptake was confined to macrophages and that BCG- 
PM displayed defective endocytosis via this receptor. 
Control experiments established that the decrease in receptor function was not a 
result of nonspecific cellular injury. Phase-contrast microscopy confirmed that cells 
were viable and >95% excluded trypan blue. The defect in mannose-specific endo- 
cytosis by BCG-PM persisted after 60 h  of cultivation and still represented 25% of 
uptake by TPM and RPM, which displayed similar activity (Table I). In contrast, all 
three populations of macrophages secreted a  comparable  amount of lysozyme, an 
index of constitutive secretory activity (17). It was noted that these cultures contained 
few remaining lymphocytes and that the continued depression of endocytosis by BCG- 
PM was apparently stable and autonomous. 
Role of HeOe and PA  Secretion.  It is  known from previous studies that  BCG-PM 
obtained after intraperitoneal infection release H202 (24) and superoxide anion (O~') 
in  response  to phorbol  myristate acetate  (PMA)  and that  peritoneal macrophages 
obtained  after BCG  infection by  the  intravenous  route  secrete  high  levels  of PA, 
especially  after  further  stimulation  by  purified  protein  derivative  of tuberculin- 
induced lymphokines. Although TPM also produce O~ and PA, H202 seems to be 
consumed by an ingredient of thioglycollate broth, and since because TPM do not 
display enhanced microbicidal or cytocidal activity, they are therefore considered not 
to be activated. It was therefore important to examine the secretory activity of BCG- 
PM in our studies and to establish that they were indeed activated according to these 
criteria.  Fig. 4 shows that  BCG-PM with reduced specific uptake of 125I-mannose- 
BSA produced similar levels of PA compared with TPM, and responded to PMA by 
releasing H202  at  levels comparable  with  those reported  by others.  TPM  did not R,  EZEKOWITZ, J.  AUSTYN,  P.  STAHL,  AND  S.  GORDON 
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FIG.  2.  Specific  binding  and  uptake  of  I~I-mannose-BSA by  BCG-PM  and  TPM.  5  ×  10  b 
macrophages (MO) were cultivated for 4 h before  assay,  l~I-mannose-BSA (3 X  10  e cpm/~g) was 
added with or without 1.25 mg mannan/well. Results show average  :t: SD of pooled results of five 
independent experiments. (O) TPM;  (0) BCG-PM. 
65 66  BACILLUS CALMETTE-GUI~RIN-ACTIVATED MACROPHAGES 
Flo. 3.  Radioautographic analysis of uptake of 12~I-mannose-BSA  by BCG-PM and TPM.  4-h 
adherent macrophages were exposed to 1251-mannose  (32/tg, 1 ×  l0  s cpm//.tg), with or without 1.25 
mg mannan/ml, for 10 min at 37°C. TPM with (A) and without mannan (B), BCG-PM with (C) 
and without mannan (D). × 450. 
produce HzO2 under these conditions, but both populations released high levels of O~- 
after PMA treatment. PMA treatment also enhanced PA secretion by both cell types 
threefold, but had no significant effect on mannose-specific endocytosis. 
These studies confirmed that the BCG-PM were activated and lent further weight 
to the argument that the defect  in endocytosis was not generalized. Because oxygen 
metabolites, especially HzO2, are known to have deleterious effects on cell membranes, 
and because other macrophage products such as proteinases and prostaglandins could 
also contribute to altered activity, experiments were performed to evaluate the role of 
secretion products in mannose-receptor function. 
BCG-activated  peritoneal  cells  were  harvested  and  adherent  cell  macrophages 67 
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TABLE  I 
Mannose-specific Endocytosis and Secretion of Lysozyme by Peritoneal 
Macrophages after Cell Culture 
Specific uptake of t25I mannose-BSA 
Peritoneal  Secretion of 
Mth*  Per  Per  lysozyme$ 
5 X 10  -5 M~b  /tg cell protein 
ng/20 rain at 37°C  I~g/5 X  105 M4~ 
RPM  57 +  4.1  2.0 +  .13  7.5 +  1.3 
TPM  72 ::lz 11  2.1 ±  .20  6.9 .-e 2.1 
BCG-PM  20 ±  4.2  0.63 ±. 10  7.2 :t: 1.9 
* 5 X  105 macrophages  (M~)  were cultivated in DMEM +  10% heat-inacti- 
vated FBS for 2 h, washed,  and then cultivated in the same medium for 60 
h before assay. 
$ Conditioned medium collected over 2-60 h of culture. Pooled results of two 
independent experiments done in duplicate. Mean +  SD. 
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FIG. 4.  Receptor-mediated endocytosis  (A) and secretion  of plasminogen activator (B) and H202 
(C) by BCG-PM and TPM.  (A) and  (B) are matched experiments;  (C) is independent. 0.2 nmol 
H20~  produced by BCG cells before PMA treatment.  2,000 IU catalase +  25 /ig/ml superoxide 
dismutase inhibited all H202 production. BCG-PM produced 301, and TPM 175 nmol superoxide/ 
90 min per mg cell protein after treatment with PMA, respectively,  iq~, macrophages. 
prepared  and  assayed  in the continuous  presence of a  cocktail of inhibitors.  Table  II 
shows  that  catalase  and  superoxide  dismutase,  at  concentrations  which  inhibited 
H202  and  O~" effectively in  independent  assays,  did  not  restore  M,FR  activity,  nor 
did  the  further  addition  of indomethacin.  Minor  inhibition  of receptor  activity was 
noted  with  both  BCG-PM  and  TPM,  but  the  cells  remained  viable.  In  other 
experiments  (data  not  shown),  sublethal  concentrations  of 0.1  mM  reagent  H202 
added  for  30  min,  had  no  effect  on  uptake  of 125I-mannose-BSA  by  TPM  or BCG- 
PM. 
It  is  known  that  M,FR  activity  in  rat  alveolar  macrophages  is  destroyed  by 
treatment of intact cells with trypsin, but that receptors can be rapidly reexpressed on 
the  cell  surface  from  an  intracellular  pool  (8).  It  seemed  unlikely  in  the  present 68  BACILLUS CALMETTE-GUI~RIN-ACTIVATED  MACROPI-IAGES 
TABLE II 
Inhibition of Oxygen Metabolites and of Prostaglandins Does Not Alter the 
Reduced Uptake of lenl-Mannose BSA by BCG-PM 
Inhibitors* 
None 
Catalase (2,000 U/ml) + superoxide 
dismutase (300 U/ml) 
Catalase + superoxide dismutase + 
Indomethacin (10 pg/ml) 
Specific uptake of 1zSI-mannose- 
BSA 
TPM  BCG-PM 
ng/5 x  105 M~ per 20 rain at 37°C 
78± 11  17± 1.9 
67 ± 6.2  14 ::k 2.6 
63 :k 5.2  14 -/- 1.6 
* Ceils were maintained in the continuous presence of  each inhibitor from time 
of harvest, including during all washes. 
experiments that proteolysis at the surface of the cells could account for the stable loss 
in  mannose-specific receptor  activity because all  macrophages were  maintained  in 
fetal  bovine  serum,  which  is  strongly  inhibitory  for  extracellular  proteolysis,  and 
because TPM, which secrete high levels of PA (25) and several other neutral proteinase 
activities showed no defect in receptor activity. Nevertheless, the role of macrophage 
proteinase secretion was examined by cultivating TPM in serum-free media and by 
cocuhivating TPM with BCG-PM. 
Adherent TPM were prepared in DMEM +  5% FBS that had been acid treated to 
reduce protease inhibitory activity (20). The monolayers were washed thoroughly and 
then  cultivated in  Dulbecco's medium with 0.1%  lactalbumin  hydrolysate for 24 h 
before assay. There was no reduction in 125I-mannose-BSA uptake, but, rather, a small 
enhancement, probably a result of the absence of serum glycoproteins able to compete 
for binding of the ligand. 
Equal numbers of TPM and BCG-PM were also mixed and cocultivated with or 
without serum for 24 h before assay. The presence of BCG-PM had no effect on TPM 
receptor activity compared with unmixed controls. 
We  concluded  that  diffusible  secretory products  could  not  account  for reduced 
receptor expression on BCG-PM. These studies did not rule out an intracellular site 
of action for these products, unique enzymes produced only by BCG-PM, or pathways 
not inhibited by this limited range of inhibitors. 
Quantitative  Assays of Other Surface Markers.  We next asked whether BCG-activated 
macrophages also expressed reduced levels  of other receptors for endocytosis and of 
other macrophage surface antigens. We examined expression of FcR receptors, which 
bind and internalize immune complexes, and of macrophage-specific antigen F4/80, 
using rat monoclonal antibodies 2.4G2 and F4/80 in a  quantitative indirect-binding 
assay.  Antibody bound to macrophages was detected  by 125I-RAR,  with  both  first- 
and second-stage antibodies at saturation. Similar assays were performed to quantitate 
expression  of Ia antigens,  which  have been  reported  on BCG-PM  (26).  The  mouse 
monoclonal antibody used, OX-4, reacts with polymorphic Ia determinants  17 or  18 
(14),  which are present in CBA (H-2k),  but not in BALB/c (H-2  d)  mice. All antigens 
were therefore examined in  matched groups of animals of both strains.  Preliminary 
studies confirmed that peritoneal macrophages obtained after BCG infection of these R.  EZEKOWITZ, J.  AUSTYN, P.  STAHL, AND S.  GORDON 
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FIo.  5.  Expression  of antigens on peritoneal macrophages measured by saturation binding assays. 
BCG-PM, RPM, and TPM were obtained from both CBA (panels A, C, and E) and BALB/c mice 
(panels  B, D, and F). 3 ×  105 peritoneal macrophages were cultured in 96-well microtiter plates in 
DMEM +  5% FBS for 4 h, washed, and assayed as described in Materials and Methods. The rabbit 
F(ab')2 antibody used to detect binding of rat (anti-F4/80, FcR) and mouse (anti-Ia H-2  k) antibodies 
was used at 7.6 ×  10  s cpm//.tg. 
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strains  spread  rapidly  and  displayed  reduced  mannose-receptor  activity  similar  to 
that  observed with macrophages  from PO  mice. 
BCG-activated CBA macrophages assayed after 4-h adherence and washing showed 
a  striking  threefold  increase  in  expression  of Ia  antigen  compared  with  TPM  and 70  BACILLUS  CALME'VrE-GUI~RIN-ACTIVATED  MACROPHAGES 
RPM  from  the same strain  (Fig.  5).  Binding of antibody was <1%  in  the BALB/c 
strain control and was therefore a  result of Ia antigen on CBA cells and not to FoR or 
cytophilic antibody. The enhanced  expression of Ia antigen  was  stable after 3  d  of 
cultivation in DMEM  +  10% FBS. 
In contrast,  BCG-PM  showed  reduced expression of F4/80  and  of FcR,  with  no 
difference between  strains.  F4/80  expression was  greatest  on  resident  macrophages 
(71,000  molecules  RAR  bound),  reduced  in  TPM  (28,000-40,000),  and  markedly 
reduced  (18,000-20,000)  in  BCG-PM,  in  agreement  with  previous  results.  2  FoR 
expression  on  BCG-PM  was  also clearly reduced  compared  with  TPM  (12,000  vs. 
56,000),  but  RPM  expressed  rather  less  antigen  (15,000-22,000),  relative to  TPM. 
Because FcR is not confined to macrophages, it should be noted that there were <  10% 
lymphoeytes and PMN  in any of these preparations. 
Reduced expression of F4/80 and FoR combined with enhanced Ia antigen was a 
consistent finding in at least five independent experiments. 
Single-Cell Analysis.  To  identify the cells labeled by each  antibody and  to detect 
possible heterogeneity, we next examined the adherent populations by radioautogra- 
phy. Results are shown in Table III and Fig. 6. F4/80 antigen was readily detectable 
on  >90%  of TPM  (>50  grains/cell)  and  was  reduced  on  BCG-PM  (40%  of cells 
heavily labeled), but 83% of cells were still clearly, though  less heavily, labeled (>20 
grains/cell) compared with control preparations without first-stage antibody. Because 
the small number  (<10%)  of remaining lymphocytes, PMN, and dendritic cells were 
all unlabeled by F4/80, these results confirm that the majority of adherent BCG-PM 
express this macrophage-specific antigen. 
In contrast, expression of Ia antigen increased from  16%  (TPM)  to 64%  (BCG-PM) 
and  was  restricted to cells from  the CBA strain.  Most cells showed  heavy labeling, 
resembled the cells labeled by F4/80,  and were therefore macrophages.  No morpho- 
TABLE  III 
Radioautographic Analysis of Antigens on BCG-PM and TPM* 
Strain  Cells~ 
Control 
without 
first-stage 
antibody 
Cells labeled by antibody 
F4/80  OX-4  2.4G2 
% 
CBA  TPM (A)  1  90+2  12±3  88+4 
TPM (B)  1  93+3  16±2  92+_2 
CBA  BCG-PM (A)  1  40 + 3  59 ± 3  20 ±  7 
BCG-PM (B)  1  85 + 2  64 + 4  89 + 2 
BALB/c  BCG-PM (A)  l  41 + 3  1  ND 
BCG-PM (B)  1  83 ~ 5  1  ND 
* Peritoneal  cells were cultured for 4 h in DMEM +  5% FBS on glass cover slips, 
washed well, and incubated with saturating concentrations of monoclonal antibody 
followed by 125I rabbit F(ab')2 antibody at trace levels (3 ×  105 cpm/0.5/~g). 
:~ 300 cells counted  in triplicate preparations.  (A) and  (B) indicate  the percent  of 
adherent cells with >50 and >20 grains, respectively. Mean ztz SD shown. Differ- 
ential count: 90% macrophages, 6% lymphocytes, 3% PMN, and 1% dendritic cells 
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Flo. 6.  Radioautographic analysis of antigen F4/80 and Ia on BCG-PM and TPM. 4-h adherent 
macrophages were incubated with saturating concentrations of monoclonal antibody and binding 
detected with trace-labeled 125I-RAR  as described in Materials and Methods. Antigen F4/80  on 
CBA-PM. (1 A) Control without antibody F4/80. (Similar results obtained for TPM or BCG-PM.) 
(1 B) TPM with  F4/80.  (1 C)  BCG-PM with  F4/80.  Ia antigen,  all with  antibody  OX-4  (2 A) 
BALB/c BCG-PM, strain control. (2 B) CBA TPM. (2 C) CBA BCG-PM. × 300. 
logic difference  was noted  between  Ia-positive and  Ia-negative macrophages.  Small 
numbers of dendritic cells seen also expressed Ia antigen strongly (26). 
Expression of FcR was similar to that of F4/80.  ~90% of TPM were heavily labeled 
by 2.4G2, whereas most BCG-PM showed reduced labeling.  Because it is known from 
other  studies  that  BCG-activated  macrophages  have  functional  Fc  receptors  (27), 
experiments  were  performed  to examine  binding  and  uptake  of sheep  erythrocytes 
opsonized with  rabbit  antibody  (IgG).  The  results,  not shown,  confirmed  that  FcR 
could be detected  on most of the BCG-PM cells by a  rosetting assay, but  that  these 
cells bound and ingested fewer antibody-coated erythrocytes than TPM. 
It can therefore be concluded that the decreased expression of surface determinants 
and  of endocytosis by  BCG-activated  macrophages  was  not  restricted  to  mannose- 
specific  receptors,  but  was  also  evident  with  two  independent  markers,  F4/80  and 
FcR. Moreover, the same population of cells expressed  increased levels of Ia antigen, 
and most of the cells that displayed this altered phenotype were macrophages. 
Phagocytosis of BCG Organisms by RPM.  The effect ofphagocytosis of BCG organisms 
on  the expression  of F4/80,  2.4G2,  Ia antigens,  and  on the uptake of 125I-mannose- 
BSA was studied  as described  in  Materials  and  Methods.  Phagocytosis of organisms 
in vitro failed to induce the changes in antigen expression seen after infection in vivo. 72  BACILLUS  CALMETTE-GUI~RIN-ACTIVATED  MACROPHAGES 
Stained preparations revealed that there were five to six organisms per macrophage 
and that 80% of the adherent cells had intracellular organisms.  2% of the adherent 
cells had intracellular organisms after BCG infection in vivo l0 d before harvest. We 
concluded that phagocytosis of organisms could not by itself account for the altered 
surface phenotype of BCG-PM (23). 
Discussion 
The plasma membrane of the activated macrophage must play an important role 
in  its ability to recognize and destroy invading microorganisms. The activated cell 
spreads  more  rapidly  on  a  foreign  surface;  the  killing  of an  extracellular  target 
depends on close contact, e.g., via antibody and Fc receptors (27), and its ability to 
release H~O~ is triggered by surface-active agents such as PMA or lectins, which have 
little effect on nonactivated macrophages (4, 6). Yet, we know little about changes in 
surface properties of macrophages upon activation or how secretory, microbicidal, or 
cytotoxic activities are controlled by external stimuli. 
In this study, we have demonstrated, with quantitative assays for several receptors 
and  antigens,  that  mouse  BCG-PM  display  markedly  different surface  properties 
compared with TPM or cells obtained from untreated animals. The BCG-PM showed 
a clear reduction in mannosyl receptor and FcR function and of antigen F4/80, but 
enhanced expression of Ia antigenic determinants. Only the BCG-PM released high 
levels of HzO2 after stimulation by PMA, and these cells were therefore regarded as 
activated. Changes in the surface markers studied here made it possible to discriminate 
between BCG-PM and nonactivated macrophages, unlike previous studies in which 
TPM also displayed a reduced level of 5' nucleotidase activity (28) as well as enhanced 
secretion of plasminogen activator (25). 
Single-cell analysis confirmed that the vast majority of BCG-PM under study still 
expressed the  macrophage-specific markers  F4/80  and  the mannosyl receptor, and 
that  Ia  antigen  expression had  been  induced on  macrophages  and  was  not  being 
detected on B lymphocytes or dendritic cells. Adherence itself did not cause the loss 
in  mannosyl  receptor or  F4/80  because  freshly harvested  cells  displayed  similarly 
reduced activity. Control experiments showed that cell injury by secretion products 
could not account for reduced endocytosis ofmannose-BSA. Because altered expression 
of all surface markers persisted for 60 h in culture, we concluded that BCG infection 
had generated a population of macrophages with a stable reversal in surface pheno- 
type.  It  remains  to  be  shown  that  other  activating  agents  bring  about  a  similar 
change. 
Because binding assays were performed on live cells at 4°C, the reduced binding of 
ligands and antibodies by BCG-PM indicates that expression of these receptors and 
antigens at the cell surface was diminished, and thus accounts for decreased uptake 
and degradation of mannose-terminated glycoconjugates. Reduced uptake at  37°C 
provides  evidence  against  the  presence  of a  substantial  intracellular  pool  of the 
mannosyl receptor in BCG-PM. The M,FR (30,000 tool wt), FcR (47,000-60,000 tool 
wt) (15), F4/80 antigen (160,000 tool wt) 2 and Ia antigen (28,000-32,000 mol wt) (14) 
are on distinct molecules and the determinants are independent of one another, e.g., 
antibody F4/80 or mannan do not block any other marker (unpublished observation). 
The coordinate reduction of three determinants and induction of Ia could conceivably R.  EZEKOWITZ, J.  AUSTYN, P.  STAHL, AND S.  GORDON  73 
be a result of a  common biosynthetic event, e.g., glycosylation, but we feel that it is 
likely to reflect a more complex change during membrane biogenesis. 
Studies  with  other antigens  and  ectoenzymes, e.g.,  5'  nucleotidase and  alkaline 
phosphodiesterase (29) might help to establish the selectivity of changes in the plasma 
membrane of the activated macrophage.  Because receptor-mediated, and  possibly- 
fluid phase, pinocytosis (30) are reduced in BCG-activated macrophages, it is unlikely 
that  enhanced  internalization  alone could account  for decreased expression at  the 
surface.  Quantitative  assessments  of the  synthesis,  internalization,  turnover,  and 
possible recycling of all the molecules concerned should yield further insights into the 
cellular mechanisms responsible. It should also be noted that uptake of  BCG organisms 
is known to inhibit phagolysosomal fusion (31) and to reduce phagocytosis of various 
particulates, with or without opsonins (23). In our studies, the peritoneal macrophages 
• obtained after infection contained few detectable organisms and the surface changes 
in these cells could not be mimicked in uninfected cells by uptake of BCG organisms 
in vitro. 
Two hypotheses can be proposed to account for the changes in plasma membrane 
observed, viz., that the cell population is changed and represents an earlier stage or 
alternate pathway of macrophage differentiation or that the mature macrophage is 
able to modulate its surface phenotype. In this regard, it is known that Ia-like antigens 
may be expressed during earlier stages of myeloid differentiation (32), but that these 
antigens can also be induced on inflammatory peritoneal macrophages by treatment 
with lymphokines (11).  It remains to be seen whether lymphokines can also induce 
the loss of F4/80 and other markers in nonactivated macrophages in vitro. 
Several  other  studies  have  noted  reduced  FcR-mediated  phagocytosis  in  some 
macrophages obtained after immunization with BCG (30) or infection by Mycobacterium 
leprae (33). It has also been argued for some time that epithelioid cells in BCG-induced 
granulomata show little morphologic evidence of endocytic activity (34). The present 
studies  indicate  that  reduced  ingestion  of antibody-coated  tumor  cells  (27)  and 
resultant extracellular lysis could be a result of the decreased number of FcR on the 
surface  of the  BCG-PM.  Although  an  extracellular  mode  of killing  resembles  a 
phagocytic mechanism in many respects, the known ability of an activated macro- 
phage to destroy intracellular pathogens needs to be considered in the light of its poor 
phagocytic activity.  Moreover, diminished  clearance of fl-glucuronidase and  other 
lysosomal hydrolases via mannosyl receptors may exacerbate extracellular catabolism 
and tissue injury. 
The possible role of Ia antigens  in  interactions between macrophages and  other 
cells or in control of their effector functions remains unclear. Nussenzweig et al. (26) 
have provided evidence that Ia positive macrophages do not actively sensitize T  cells 
in a  model immune response, unlike small numbers of dendritic cells that  induced 
strong responses. Because activated macrophages express Ia antigens in common with 
other  cells  and  because  expression  of the  currently available  macrophage-specific 
markers decreases during activation, it is necessary to produce new markers specific 
for the activated macrophage to study its contribution to immune responses. Studies 
to this end are in progress in our laboratory. 
Summary 
Infection  of the  mouse  peritoneal  cavity  by  bacillus  Calmette-Gu~rin  (BCG) 
markedly alters the surface properties of the macrophages induced, compared with 74  BACILLUS CALMETTE-GUI~RIN-ACTIVATED  MACROPHAGES 
cells  obtained  from  uninfected  control  animals  or  after  injection  of thioglycollate 
broth.  Quantitative  binding assays with  radiolabeled  ligands  or antibodies  showed 
that BCG-activated peritoneal macrophages (BCG-PM) expressed one-fourth or less 
receptor activity for mannose-terminal glycoeonjugates as well as reduced levels of Fc 
receptors and of antigen F4/80 compared with nonactivated macrophages. Endoey- 
tosis  mediated  by  mannose-specific receptors was  reduced  in  parallel.  In  contrast, 
surface Ia antigen was increased threefold in the same adherent cell population. 
Radioautographic  analysis confirmed that  >80%  of adherent  cells still expressed 
low levels of the macrophage-specific mannosyl receptor and antigen F4/80, and that 
Ia antigens  had  been  induced  on  64%  of macrophages rather  than  on other cells. 
Control experiments established that only the BCG-PM macrophages released H202 
after stimulation with phorbol myristate acetate, whereas both BCG-PM and thiogly- 
collate-induced macrophages produced superoxide anion and plasminogen activator. 
The BCG-PM were viable, secreted normal levels of lysozyme, and displayed a stable 
phenotype after cultivation  for 60 h.  Inhibitors of oxygen products, prostaglandins, 
and proteases did not alter reduced endocytosis by BCG-PM. 
These studies indicated that expression of macrophage surface markers is reversed 
by  BCG-activation,  and  that  their  known  enhanced  ability  to  lyse  target  cells 
extracellularly is associated with decreased endocytosis via specific receptors. Whether 
these changes are a  result of an altered cell population or of modulation of selective 
surface properties is not known. 
We thank Stan Hirsch, David Vaux, and Dr. Roger Gingrich for helpful discussions and Dr. 
Giorgio Berton for performing the H202 assays. 
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